Driftoff

Driftoff

ZHOU4.0 (3,405 ratings)
Format:Capsule Quantity: 60 Capsule(s) · 30 servings
Goals

Product analysis

47 out of 100

Driftoff centres on melatonin for sleep timing and falling asleep, with more uncertain calming support from the other ingredients. The herbal preparations are not clearly specified, making their likely contribution harder to judge.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality20

The ingredient preparations are unspecified, preventing a direct quality comparison. The herb names alone do not establish equivalence to particular extracts.

Ingredient Transparency63

The ingredient amounts are disclosed, making the serving easier to check. Missing forms leave the preparations harder to compare with alternatives.

Value For Money38

The valerian and GABA comparisons are less favourable, and melatonin is relatively costly. Other comparisons are incomplete, leaving no clear value advantage for the combination.

Customer Satisfaction71

Customer feedback is positive on average across a large number of reviews. Those experiences describe satisfaction without proving sleep or mood benefits.

Product Focus71

Melatonin provides the clearest link to sleep timing and falling asleep. The other ingredients add more uncertain relaxation support, with limited basis for broad daytime stress or mood benefits.

Format
Capsule
Container
60 Capsule(s)
Per serving
$0.70
Customer rating
4.0 · 3,405 ratings
Report analysis

Goals

Sleep Support
Impact
Highest effect
B Ingredient FitC PathwaysA+ EvidenceA+ Formulation Logic
Melatonin · 2 mg

Melatonin is the main ingredient for sleep timing and falling asleep. GABA, valerian, chamomile and lemon balm add possible calming or sleep-quality connections, but their evidence is limited or mixed and the amounts provide less support than melatonin. Valerian extract identity alone does not establish equivalence to a defined medicinal extract. Tryptophan and passionflower are too low to contribute in the saved findings, and arbitrary hops extract has no established independent sleep contribution.

How this product is rated for Sleep Support

Ingredient fit77

The formula is sleep-focused, but most companion ingredients receive only partial amount recognition.
Goal fit
The recognized ingredients largely fit sleep support.
Dose adequacy
Melatonin is fully recognized; the calming companions receive partial amount recognition, while tryptophan and passionflower are excluded.

Pathways60

Sleep timing dominates; calming remains less substantially represented.
Depth
Melatonin supplies the strongest sleep-clock connection.
Breadth
Only timing reaches substantial coverage, despite several calming ingredients.

Evidence100

Melatonin provides the strongest evidence; the companion ingredients have more limited or mixed support.
Evidence strength
Melatonin supplies the strongest reviewed sleep support.
Studied preparation
The saved findings recognize the included preparations, without establishing equivalence to specific medicinal valerian extracts.

Formulation logic100

Recognized ingredients have no missing partner or matched conflict.
Partner coverage
The recognized ingredients work alone or have their required partner.
Conflicts
No ingredient conflict is matched.
Effective doses
Five ingredients meet the inclusion threshold; tryptophan and passionflower do not, and hops receives no independent contribution.
Study evidence
GABA Supportive 4 studies
Melatonin Supportive 181 studies
Valerian Supportive 31 studies
Stress Relief
Impact
Highest effect
B- Ingredient FitB+ PathwaysA EvidenceA+ Formulation Logic
GABA · 100 mgTryptophan · 100 mg

GABA has limited short-term task-stress findings, while sustained supplement benefits remain uncertain. Melatonin connects mainly with sleep-associated or selected procedural anxiety contexts. Valerian, accompanied by hops, adds a sleep-related connection, although its outcomes are inconsistent and its amount contributes only partially. Driftoff therefore relates mainly to sleep recovery and calming, with little basis here for broad daytime stress relief.

How this product is rated for Stress Relief

Ingredient fit72

GABA, melatonin and valerian provide the main contributions within a broader sleep formula.
Goal fit
GABA, melatonin and valerian provide the main contributions within a broader sleep formula.
Dose adequacy
Amounts provide partial support overall, especially for GABA and valerian.

Pathways80

Sleep recovery and calming are the main relevant aspects.
Depth
Sleep recovery has the strongest combined coverage.
Breadth
Sleep recovery and calming are covered; other stress aspects are not.

Evidence91

GABA supplies the strongest saved evidence, but the relevant findings concern limited short-term settings.
Evidence strength
GABA supplies the strongest saved evidence, but the relevant findings concern limited short-term settings.
Studied preparation
The contributing ingredients with sufficient amounts meet the saved studied-preparation comparison.

Formulation logic100

The contributing ingredients work independently or have their relevant partners, with no flagged formulation conflict.
Partner coverage
Hops provides valerian's relevant partner; the other contributing ingredients work independently.
Conflicts
No configured ingredient conflict is identified in the supplied facts.
Effective doses
All credited ingredients meet the minimum amount threshold for a contribution.
Study evidence
GABA Supportive 6 studies
Melatonin Supportive 21 studies
Valerian Supportive 18 studies
Mood Support
Impact
Moderate effect
C Ingredient FitF PathwaysD+ EvidenceA+ Formulation Logic

Lemon balm may help ease anxiety or depressive symptoms, though the effect varies with the preparation. The serving contains 100 mg of lemon balm, and the limited information about this preparation leaves its likely effect uncertain. Valerian is more closely associated with relaxation and sleep; whether it directly improves everyday mood is unclear.

How this product is rated for Mood Support

Ingredient fit62

Valerian mainly relates to relaxation and sleep; a direct everyday mood benefit is unclear.
Goal fit
Valerian mainly relates to relaxation and sleep; a direct everyday mood benefit is unclear.
Dose adequacy
Valerian provides 150 mg per serving; this amount alone doesn't predict mood improvement.

Pathways11

The main connection concerns calming, which is narrower than a general improvement in mood.
Depth
The main connection concerns calming, which is narrower than a general improvement in mood.
Breadth
The mood connection is narrow; additional emotional effects cannot be assumed from ingredient mechanisms.

Evidence55

Valerian mainly relates to relaxation and sleep; a direct everyday mood benefit is unclear.
Evidence strength
Valerian mainly relates to relaxation and sleep; a direct everyday mood benefit is unclear.
Studied preparation
The botanical declaration is available, but different extracts aren't automatically interchangeable.

Formulation logic100

Valerian does not depend on a companion ingredient here. No particular conflict among the listed ingredients is identified.
Partner coverage
Valerian does not require another listed ingredient for its potential contribution.
Conflicts
No particular conflict among the listed ingredients is identified.
Effective doses
Valerian provides 150 mg per serving; this amount alone doesn't predict mood improvement.
Study evidence
GABA Supportive 12 studies
Valerian Supportive 17 studies

Ingredients

IngredientAmount per servingScore
Valerian extract
150 mg 64
GABA
100 mg 69
L-Tryptophan
100 mg
Chamomile extract
100 mg
Passion Flower extract
100 mg
Lemon Balm extract
100 mg
Hops extract
100 mg
Melatonin
2 mg 46
Gluten Free Adults 18–50 Vegetarian
Report overview
GABA · 100 mg OverallScore69
B- Active Ingredient Quality & BioavailabilityB+ Dose, Safety & Label TransparencyD- Value
Each serving provides 100 mg GABA, identified as generic in the saved facts. A whole-product serving costs about $0.70.
How this ingredient is rated

Active Ingredient Quality & Bioavailability70

The saved facts identify generic GABA; its production method is not established in those facts.
GABA Source & Production Method
The saved facts identify generic GABA; its production method is not established in those facts.

Dose, Safety & Label Transparency82

Each serving provides 100 mg GABA, with the amount stated separately. The evaluation flags common flow agents in the ingredient panel.
GABA Dosage Adequacy & Transparency
Each serving provides 100 mg GABA, with the amount stated separately.
Label Purity & Excipient Quality
The evaluation flags common flow agents in the ingredient panel.

Value40

At about $0.70 per whole-product serving, the price is relatively high in the evaluation for this GABA source.
Price per Effective Dose
At about $0.70 per whole-product serving, the price is relatively high in the evaluation for this GABA source.
Melatonin · 2 mg OverallScore46
F Active Ingredient Quality & BioavailabilityA+ Dose, Safety & Label TransparencyF Value
A serving supplies 2 mg of melatonin in capsule form. The whole-product serving costs about $0.70.
How this ingredient is rated

Active Ingredient Quality & Bioavailability0

The saved information contains no qualifying independent-testing claim, so independent verification is unknown.
Third-Party Purity Verification
No qualifying independent-testing claim is recorded in the saved information; that does not establish whether testing occurred.

Dose, Safety & Label Transparency100

The 2 mg serving is among the lower amounts in this comparison.
Physiological Dosing Alignment
Each serving contains 2 mg of melatonin, a lower amount in this comparison.

Value30

The whole-product serving costs about $0.70.
Price Per Serving Efficiency
The price is about $0.70 per whole-product serving.
Valerian · 150 mg OverallScore64
D- Composition And Label DisclosureA+ Composition And Label DisclosureD- Commercial Price And Usability
Each serving provides 150 mg of valerian extract. The whole-product serving costs about $0.70.
How this ingredient is rated

Composition and Label Disclosure40

The valerian extract is identified, but the available facts do not provide an extract ratio or valerenic acid percentage.
Marker and Preparation Disclosure
The extract is identified, but its ratio and valerenic acid percentage are not specified in the available facts.

Composition and Label Disclosure100

The available facts give 150 mg of valerian extract per serving.
Individual Preparation Amount Disclosure
The available facts give 150 mg of valerian extract per serving.

Commercial Price and Usability40

A whole-product serving costs about $0.70; this is the price for the full serving.
Commercial Price per Labeled Serving
The whole-product serving costs about $0.70.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Oral intake of γ-aminobutyric acid affects mood and activities of central nervous system during stressed condition induced by mental tasks.
    Yoto A; Murao S; Motoki M; Yokoyama Y; Horie N; Takeshima K; Masuda K; Kim M; Yokogoshi H · Amino acids · 2012
    Randomized trial63 participantsMood Support Stress Relief forGABA
  2. Peripartum neuroactive steroid and γ-aminobutyric acid profiles in women at-risk for postpartum depression.
    Deligiannidis KM; Kroll-Desrosiers AR; Mo S; Nguyen HP; Svenson A; Jaitly N; Hall JE; Barton BA; Rothschild AJ; Shaffer SA · Psychoneuroendocrinology · 2017
    Cohort study56 participantsMood Support forGABA
  3. The role of neurotransmitters in mediating the relationship between brain alterations and depressive symptoms in patients with inflammatory bowel disease.
    Wang J; Liu G; Xu K; Ai K; Huang W; Zhang J · Human brain mapping · 2023
    Case-control study69 participantsMood Support forGABA
  4. Occipital gamma-aminobutyric acid and glutamate-glutamine alterations in major depressive disorder: An mrs study and meta-analysis.
    Truong V; Cheng PZ; Lee HC; Lane TJ; Hsu TY; Duncan NW · Psychiatry research. Neuroimaging · 2021
    Observational studyMood Support forGABA
  5. Systematic review of gamma-aminobutyric-acid inhibitory deficits across the reproductive life cycle.
    Vigod SN; Strasburg K; Daskalakis ZJ; Blumberger DM · Archives of women's mental health · 2014
    Systematic review11 studies pooledMood Support forGABA
  6. A systematic review of the effect of L-tryptophan supplementation on mood and emotional functioning
    Kikuchi AM, Tanabe A, Iwahori Y · Journal of Dietary Supplements · 2021
    Systematic review11 studies pooledMood Support forTryptophan
  7. Standardized Extract of Valeriana officinalis Improves Overall Sleep Quality in Human Subjects with Sleep Complaints: A Randomized, Double-Blind, Placebo-Controlled, Clinical Study.
    Chandra Shekhar H; Joshua L; Thomas JV · Advances in therapy · 2024
    Randomized trial80 participantsMood Support Sleep Support Stress Relief forValerian
  8. Chemotypic diversity and neuroactive potential of Valeriana jatamansi Jones: a systematic review on phytochemistry, pharmacology and standardisation challenges.
    Nisar S; Jan N; Hassan I; Andleeb L; Shabir PA · Natural product research · 2026
    Meta-analysis12 studies pooledMood Support forValerian
  9. Valerian Root in Treating Sleep Problems and Associated Disorders-A Systematic Review and Meta-Analysis.
    Shinjyo N; Waddell G; Green J · Journal of evidence-based integrative medicine · 2021
    Meta-analysis6,894 participants60 studies pooledMood Support forValerian
  10. Assessment of Valeriana officinalis l. (Valerian) for Conscious Sedation of Patients During the Extraction of Impacted Mandibular Third Molars: A Randomized, Split-Mouth, Double-Blind, Crossover Study.
    Farah GJ; Ferreira GZ; Danieletto-Zanna CF; Luppi CR; Jacomacci WP · Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons · 2020
    Randomized trial20 participantsMood Support forValerian
  11. Effectiveness and safety of oral sedation in adult patients undergoing dental procedures: a systematic review.
    Araújo JO; Bergamaschi CC; Lopes LC; Guimarães CC; de Andrade NK; Ramacciato JC; Motta RHL · BMJ open · 2021
    Systematic review327 participants12 studies pooledMood Support Stress Relief forValerian
  12. Safety and Efficacy of Gamma-Aminobutyric Acid from Fermented Rice Germ in Patients with Insomnia Symptoms: A Randomized, Double-Blind Trial.
    Byun JI; Shin YY; Chung SE; Shin WC · Journal of clinical neurology (Seoul, Korea) · 2020
    Randomized trial40 participantsSleep Support forGABA
  13. Analysis of the Effects of Known Sleep-Support Supplements in Relation to Life Habits, Sleep Conditions, and Sleep Problems.
    Imafuku F; Yamamoto K; Tanaka E; Aoki R; Nishino S · Nutrients · 2023
    Randomized trial160 participantsSleep Support forGABA
  14. Reduced γ-aminobutyric acid in occipital and anterior cingulate cortices in primary insomnia: a link to major depressive disorder?
    Plante DT; Jensen JE; Schoerning L; Winkelman JW · Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2012
    Case-control study40 participantsSleep Support forGABA
  15. GABA Supplementation, Increased Heart-Rate Variability, Emotional Response, Sleep Efficiency and Reduced Depression in Sedentary Overweight Women Undergoing Physical Exercise: Placebo-Controlled, Randomized Clinical Trial.
    Guimarães AP; Seidel H; Pires LVM; Trindade CO; Baleeiro RDS; Souza PM; Silva FGDE; Coelho DB; Becker LK; Oliveira EC · Journal of dietary supplements · 2024
    Randomized trial30 participantsSleep Support Stress Relief forGABA
  16. Meta-analysis: melatonin for the treatment of primary sleep disorders.
    Ferracioli-Oda E; Qawasmi A; Bloch MH · PloS one · 2013
    Meta-analysis1,683 participants19 studies pooledSleep Support forMelatonin
  17. Melatonin treatment for age-related insomnia.
    Zhdanova IV; Wurtman RJ; Regan MM; Taylor JA; Shi JP; Leclair OU · The Journal of clinical endocrinology and metabolism · 2001
    Randomized trial30 participantsSleep Support forMelatonin
  18. The Effectiveness of Melatonin for Sleep Disturbances in Parkinson' Disease: Systematic Review and Meta-Analysis.
    Yousef O; Abouelmagd ME; Khaddam H; Shbani A; Yousef R; Meshref M; Hanafi I · Journal of sleep research · 2026
    Meta-analysis409 participants8 studies pooledSleep Support forMelatonin
  19. Nightly treatment of primary insomnia with prolonged release melatonin for 6 months: a randomized placebo controlled trial on age and endogenous melatonin as predictors of efficacy and safety.
    Wade AG; Ford I; Crawford G; McConnachie A; Nir T; Laudon M; Zisapel N · BMC medicine · 2010
    Randomized trial791 participantsSleep Support forMelatonin
  20. Effects of exogenous melatonin on sleep: a meta-analysis.
    Brzezinski A; Vangel MG; Wurtman RJ; Norrie G; Zhdanova I; Ben-Shushan A; Ford I · Sleep medicine reviews · 2005
    Meta-analysis284 participants8 studies pooledSleep Support forMelatonin